Patents by Inventor Anna Claire Maurer

Anna Claire Maurer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses
    Patent number: 11958884
    Abstract: Methods and compositions are provided that can be used to modify the assembly activating protein (AAP)-dependence of an adeno-associated virus (AAV).
    Type: Grant
    Filed: May 21, 2021
    Date of Patent: April 16, 2024
    Assignees: Massachusetts Eye and Ear Infirmary, The Schepens Eye Research Institute, Inc.
    Inventors: Luk H. Vandenberghe, Anna Claire Maurer
  • METHODS AND COMPOSITIONS FOR MODIFYING ASSEMBLY-ACTIVATING PROTEIN (AAP)-DEPENDENCE OF VIRUSES
    Publication number: 20210292374
    Abstract: Methods and compositions are provided that can be used to modify the assembly activating protein (AAP)-dependence of an adeno-associated virus (AAV).
    Type: Application
    Filed: May 21, 2021
    Publication date: September 23, 2021
    Inventors: Luk H. Vandenberghe, Anna Claire Maurer
  • Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses
    Patent number: 11034732
    Abstract: Methods and compositions are provided that can be used to modify the assembly activating protein (AAP)-dependence of an adeno-associated virus (AAV).
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: June 15, 2021
    Assignees: Massachusetts Eye and Ear Infirmary, The Schepens Eye Research Institute, Inc.
    Inventors: Luk H. Vandenberghe, Anna Claire Maurer
  • PRODUCTION OF ADENO-ASSOCIATED VIRUSES IN INSECT CELLS
    Publication number: 20200231986
    Abstract: This disclosure relates to the field of high scale production of recombinant Adeno-Associated Viruses (AAVs). The inventors have conceived of specific nucleic acid constructs that allow for high scale production of recombinant AAV particles in insect cells. Importantly, these nucleic constructs do not require the production of a heterologous AAP. This disclosure thus relates to a nucleic acid for producing AAV capsids in insect cells, where the nucleic acid includes a first open reading frame encoding the VP1, VP2, and VP3 proteins, and a second open reading frame encoding the Assembly-Activating Protein (AAP).
    Type: Application
    Filed: September 28, 2018
    Publication date: July 23, 2020
    Inventors: Eduard Ayuso, Cecile Robin, Magalie Penaud-Budloo, Achille Francois, Véronique Blouin, Luk H. Vandenberghe, Anna Claire Maurer
  • METHODS AND COMPOSITIONS FOR MODIFYING ASSEMBLY-ACTIVATING PROTEIN (AAP)-DEPENDENCE OF VIRUSES
    Publication number: 20190330278
    Abstract: Methods and compositions are provided that can be used to modify the assembly activating protein (AAP)-dependence of an adeno-associated virus (AAV).
    Type: Application
    Filed: May 10, 2019
    Publication date: October 31, 2019
    Inventors: Luk H. Vandenberghe, Anna Claire Maurer